Companion Spine
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Companion Spine - overview
Established
2020
Location
New York, NY, US
Primary Industry
Healthcare
About
Based in New York, US, and founded in 2020 by CEO Erick Cloix, and Anthony G. Viscogliosi, Companion Spine LLC provides diagnostic, interventional, and surgical total solutions for relieving back pain as well as treatment of degenerative disc disease and lumbar spinal stenosis. In February 2022, Companion Spine raised USD 55 million in a Series A funding led by Viscogliosi Brothers. Companion Spine offers interventional therapies and technologies for degenerative disc disease, spinal stenosis, injury-related pain, and general back pain.
The company is developing tools and technologies for diagnosis, pain management, interventional therapies, and surgical technologies for pain treatment that might include reversible and invasive treatments that can be performed in outpatient centers. The company plans to use its proceeds from a Series A funding to develop and commercialize its invasive diagnostic and therapeutic solutions in the US and worldwide for the treatment of spine diseases, such as degenerative disc disease (DDD) and lumbar spine stenosis (LSS).
Current Investors
Viscogliosi Brothers, Viscogliosi Brothers Watermark Holdings, Epimed International, Inc.
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment, Therapeutic Devices
Website
www.companion-spine.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.